Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP711889.RAw8egwNFVLoKhAHY3daxXi7h-aFRf_tcuSV7myrd8lQM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP711889.RAw8egwNFVLoKhAHY3daxXi7h-aFRf_tcuSV7myrd8lQM130_assertion type Assertion NP711889.RAw8egwNFVLoKhAHY3daxXi7h-aFRf_tcuSV7myrd8lQM130_head.
- NP711889.RAw8egwNFVLoKhAHY3daxXi7h-aFRf_tcuSV7myrd8lQM130_assertion description "[Gene mutations of KIT or PDGFRA are critical in GISTs, because the aberrant versions not only are correlated with the specific cell morphology, histologic phenotype, metastasis, and prognosis, but also are the targets of therapy with imatinib and other agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711889.RAw8egwNFVLoKhAHY3daxXi7h-aFRf_tcuSV7myrd8lQM130_provenance.
- NP711889.RAw8egwNFVLoKhAHY3daxXi7h-aFRf_tcuSV7myrd8lQM130_assertion evidence source_evidence_literature NP711889.RAw8egwNFVLoKhAHY3daxXi7h-aFRf_tcuSV7myrd8lQM130_provenance.
- NP711889.RAw8egwNFVLoKhAHY3daxXi7h-aFRf_tcuSV7myrd8lQM130_assertion SIO_000772 18671247 NP711889.RAw8egwNFVLoKhAHY3daxXi7h-aFRf_tcuSV7myrd8lQM130_provenance.
- NP711889.RAw8egwNFVLoKhAHY3daxXi7h-aFRf_tcuSV7myrd8lQM130_assertion wasDerivedFrom befree-20140225 NP711889.RAw8egwNFVLoKhAHY3daxXi7h-aFRf_tcuSV7myrd8lQM130_provenance.
- NP711889.RAw8egwNFVLoKhAHY3daxXi7h-aFRf_tcuSV7myrd8lQM130_assertion wasGeneratedBy ECO_0000203 NP711889.RAw8egwNFVLoKhAHY3daxXi7h-aFRf_tcuSV7myrd8lQM130_provenance.